Detalhe da pesquisa
1.
Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
Dig Dis Sci
; 64(3): 740-750, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478770
2.
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
Oncologist
; 21(11): 1315-1325, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27566247
3.
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors.
Cancer
; 118(17): 4262-70, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22294459
4.
Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors.
Invest New Drugs
; 30(1): 258-65, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20697775
5.
Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer.
Clin Cancer Res
; 26(14): 3557-3564, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303539
6.
Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical Trial.
JAMA Oncol
; 6(1): 125-132, 2020 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31580386
7.
Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months: A Single Institutional Study.
Am J Clin Oncol
; 42(6): 512-518, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30973370
8.
miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis.
Inflamm Bowel Dis
; 25(1): 78-84, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30204869
9.
Phase I and pharmacokinetic study of imatinib mesylate (Gleevec) and gemcitabine in patients with refractory solid tumors.
Clin Cancer Res
; 13(19): 5876-82, 2007 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17908982
10.
Decision-Making Strategy for Rectal Cancer Management Using Radiation Therapy for Elderly or Comorbid Patients.
Int J Radiat Oncol Biol Phys
; 100(4): 926-944, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29485072
11.
Management of locally advanced rectal cancer in the elderly: a critical review and algorithm.
J Gastrointest Oncol
; 9(2): 363-376, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29755777
12.
Adjuvant therapeutic strategies for resectable pancreatic adenocarcinoma.
Ann Pancreat Cancer
; 12018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30687847
13.
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
J Natl Cancer Inst
; 110(3): 316-320, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29155997
14.
Pharmacokinetics of cetuximab after administration of escalating single dosing and weekly fixed dosing in patients with solid tumors.
Clin Cancer Res
; 12(21): 6517-22, 2006 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17065274
15.
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
J Clin Oncol
; 23(9): 1819-25, 2005 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15774775
16.
Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.
Clin Cancer Res
; 9(5): 1673-9, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12738720
17.
Molecular Profiling for Proper Diagnosis of Gastroenteropancreatic Neuroendocrine Tumor.
JCO Precis Oncol
; 42020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923901
18.
Early vs. Late Chemoradiation Therapy and the Postoperative Interval to Adjuvant Therapy Do Not Correspond to Local Recurrence in Resected Pancreatic Cancer.
Pancreat Disord Ther
; 5(2)2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26779392
19.
Pilot study of gemcitabine (10 mg/m(2) per min) and cisplatin.
Cancer Chemother Pharmacol
; 50(1): 80-3, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12111116
20.
A phase I trial of weekly paclitaxel, 13- cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies.
Cancer Chemother Pharmacol
; 52(2): 119-24, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12768320